Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1069 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-04-14 (finimize.com)
US Markets Climb As Sectors Shine With Solid Gains -
Major indexes rose with real estate and utilities leading, while Palantir benefited from a NATO deal and Charles River Laboratories topped the S&P 500.
Read more
2025-04-06 (finanznachrichten.de)
Charles River Laboratories International, Inc.: Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the initial cohort of its Charles River Incubator Program (CIP). Launched in December 2024, the program offers early-stage biotechnology
Read more
2025-04-01 (contractpharma.com)
Charles River Integrates Akron Bio's CSS Line of Liquid Cytokines |
CGMP cytokines now available for Charles River's Cell Therapy Flex Platform.
Read more
2025-03-18 (globenewswire.com)
Leading Academic and Manufacturing Organizations Join Ori Biotech's Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies
Oribiotech Ltd. (Ori), announced the launch of its Preferred Partner Network (PPN), bringing together top AMCs and CDMOs....
Read more
2024-11-21 (chicagobusiness.com)
Biotech startup signs 2-floor lease in Evanston lab tower
Cour Pharmaceuticals plans to move its HQ out of Skokie for a custom-built, 50,000 square-foot space in Evanston Labs.
Read more
2024-10-17 (businesswire.com)
Charles River Launches New Retrogenix ® Non-Human Protein Library
Charles River launches the Retrogenix® Non-Human Protein Library to support assessment of off-target binding, de-risk studies & aid model selection.
Read more
2024-07-08 (businesswire.com)
Charles River to Perform Plasmid Manufacturing for AAVantgarde
Charles River Laboratories International, Inc. (NYSE: CRL) and AAVantgarde today announced a contract development and manufacturing organization (CDMO) agree...
Read more
2023-03-09 (iit.edu)
Illinois Tech Incubator Startup SAMDI Tech Acquired by Charles River | Illinois Institute of Technology
CHICAGO—March 9, 2023—SAMDI Tech, Inc., a leading provider of high-quality, label-free high-throughput screening (HTS) sol
Read more
2022-05-05 (businesswire.com)
Multiply Labs Adds Thermo Fisher Scientific and Charles River Laboratories to Its Robotic Manufacturing Consortium
The robotic cell therapy manufacturing Consortium founded by Multiply Labs, with initial participation from UCSF and Cytiva, announced today that Ther
Read more
(contractpharma.com)
Charles River Launches eXpDNA Plasmid Platform
Reduces plasmid development and production timelines while streamlining the development journey for cell and gene therapy and vaccine developers.
Read more